(株)メドレックスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4586/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/11/04 | 日証協 | 982,600株 | -0.21% | 21,100株 | -60.34% | 746,306株 | +2.43% | 14,800株 | -72.75% |
2016/10/28 | 日証協 | 984,700株 | +6.02% | 53,200株 | -11.04% | 728,591株 | +5.02% | 54,315株 | -42.89% |
2016/10/21 | 日証協 | 928,800株 | -9.96% | 59,800株 | +13.69% | 693,791株 | -7.44% | 95,100株 | +206.73% |
2016/10/14 | 日証協 | 1,031,500株 | +4.91% | 52,600株 | +16.37% | 749,591株 | +5.1% | 31,004株 | +57.38% |
2016/10/07 | 日証協 | 983,200株 | +0.13% | 45,200株 | 0% | 713,187株 | +0.32% | 19,700株 | +57.55% |
2016/09/30 | 日証協 | 981,900株 | +0.08% | 45,200株 | -31.93% | 710,883株 | -4.08% | 12,504株 | +1266.56% |
2016/09/23 | 日証協 | 981,100株 | +7.22% | 66,400株 | -43.39% | 741,087株 | -0.93% | 915株 | -97.76% |
2016/09/16 | 日証協 | 915,000株 | +0.72% | 117,300株 | +132.74% | 748,072株 | +1.38% | 40,900株 | +32.71% |
2016/09/09 | 日証協 | 908,500株 | +3.62% | 50,400株 | -48.09% | 737,882株 | +2.33% | 30,820株 | -49.56% |
2016/09/02 | 日証協 | 876,800株 | -8.35% | 97,100株 | +262.31% | 721,067株 | -3.05% | 61,100株 | -38.41% |
2016/08/26 | 日証協 | 956,700株 | -1.82% | 26,800株 | +68.55% | 743,727株 | -7.45% | 99,210株 | +1033.83% |
2016/08/19 | 日証協 | 974,400株 | +1.14% | 15,900株 | -73.37% | 803,627株 | +0.9% | 8,750株 | -72.13% |
2016/08/12 | 日証協 | 963,400株 | +4.33% | 59,700株 | -40.36% | 796,477株 | +0.14% | 31,401株 | -33.89% |
2016/08/05 | 日証協 | 923,400株 | -8.29% | 100,100株 | +191.84% | 795,376株 | -2.8% | 47,500株 | +347.27% |
2016/07/29 | 日証協 | 1,006,900株 | -6.49% | 34,300株 | -79.41% | 818,276株 | -7.94% | 10,620株 | -93.11% |
2016/07/22 | 日証協 | 1,076,800株 | +20.14% | 166,600株 | +4.26% | 888,856株 | +12.28% | 154,100株 | +251.83% |
2016/07/15 | 日証協 | 896,300株 | +14.18% | 159,800株 | +43.71% | 791,656株 | +3.87% | 43,800株 | +39.94% |
2016/07/08 | 日証協 | 785,000株 | -11.77% | 111,200株 | +25.23% | 762,156株 | -2.86% | 31,300株 | -57.93% |
2016/07/01 | 日証協 | 889,700株 | -4.49% | 88,800株 | -43.4% | 784,556株 | -4.26% | 74,405株 | +128.03% |
※株式分割は考慮していませんのでご注意ください。
Page Top